The clearest supported uses here are correcting low folate status and targeted use around conception or early pregnancy. The pregnancy row stays conservative under the current grading system because it reflects the supplement evidence currently shown on this page on this page, not a rejection of standard folic-acid guidance. Effects on homocysteine are mostly about a blood marker, not proven prevention of heart attack or stroke.
Each row is a different health effect. A means the support looks strongest, B likely helpful, C mixed or modest, and — not enough human evidence yet.
Papers are individual studies. Research reviews summarize evidence from multiple studies, such as systematic reviews and meta-analyses.
Safety is graded separately from benefits. Read these cautions first, especially if you take medication or have a medical condition.
Dose, form and timing based on trials in the database.
Products that pass third-party quality testing.
Product quality data coming soon
Product recommendations are being built from USP Verified, NSF Certified, and Labdoor test data. Products will only appear here after the supplement itself clears the evidence bar above — and only if the product passes third-party purity testing.
Grades come from 154 unique research papers indexed from PubMed. The folate evidence base spans deficiency-correction trials, preconception and pregnancy studies, homocysteine biomarker studies, and several more clinical or combination-product settings. Each supplement is graded by health effect using a certainty × effect matrix applied across PubMed evidence per health effect. Cochrane reviews and high-quality systematic reviews carry the most weight. From abstract-only data, "high certainty" is rare — most A grades come from moderate certainty plus consistent meaningful-positive evidence. See Methodology for full detail.